rs4065

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002658.6(PLAU):​c.*141C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.515 in 701,926 control chromosomes in the GnomAD database, including 99,198 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 20132 hom., cov: 33)
Exomes 𝑓: 0.52 ( 79066 hom. )

Consequence

PLAU
NM_002658.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0110

Publications

38 publications found
Variant links:
Genes affected
PLAU (HGNC:9052): (plasminogen activator, urokinase) This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
C10orf55 (HGNC:31008): (chromosome 10 putative open reading frame 55) Enables identical protein binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-73916706-C-T is Benign according to our data. Variant chr10-73916706-C-T is described in ClinVar as Benign. ClinVar VariationId is 300765.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.573 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLAUNM_002658.6 linkc.*141C>T 3_prime_UTR_variant Exon 11 of 11 ENST00000372764.4 NP_002649.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLAUENST00000372764.4 linkc.*141C>T 3_prime_UTR_variant Exon 11 of 11 1 NM_002658.6 ENSP00000361850.3

Frequencies

GnomAD3 genomes
AF:
0.505
AC:
76748
AN:
151990
Hom.:
20128
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.464
Gnomad AMI
AF:
0.502
Gnomad AMR
AF:
0.470
Gnomad ASJ
AF:
0.604
Gnomad EAS
AF:
0.119
Gnomad SAS
AF:
0.317
Gnomad FIN
AF:
0.469
Gnomad MID
AF:
0.661
Gnomad NFE
AF:
0.578
Gnomad OTH
AF:
0.579
GnomAD4 exome
AF:
0.517
AC:
284423
AN:
549818
Hom.:
79066
Cov.:
7
AF XY:
0.511
AC XY:
145491
AN XY:
284984
show subpopulations
African (AFR)
AF:
0.472
AC:
6775
AN:
14366
American (AMR)
AF:
0.398
AC:
7844
AN:
19694
Ashkenazi Jewish (ASJ)
AF:
0.599
AC:
8624
AN:
14390
East Asian (EAS)
AF:
0.106
AC:
3329
AN:
31482
South Asian (SAS)
AF:
0.337
AC:
16145
AN:
47882
European-Finnish (FIN)
AF:
0.460
AC:
14003
AN:
30420
Middle Eastern (MID)
AF:
0.674
AC:
1476
AN:
2190
European-Non Finnish (NFE)
AF:
0.585
AC:
210674
AN:
360136
Other (OTH)
AF:
0.532
AC:
15553
AN:
29258
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
6448
12896
19344
25792
32240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2544
5088
7632
10176
12720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.505
AC:
76778
AN:
152108
Hom.:
20132
Cov.:
33
AF XY:
0.497
AC XY:
36952
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.464
AC:
19243
AN:
41494
American (AMR)
AF:
0.469
AC:
7169
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.604
AC:
2097
AN:
3470
East Asian (EAS)
AF:
0.119
AC:
615
AN:
5178
South Asian (SAS)
AF:
0.317
AC:
1531
AN:
4826
European-Finnish (FIN)
AF:
0.469
AC:
4956
AN:
10558
Middle Eastern (MID)
AF:
0.656
AC:
193
AN:
294
European-Non Finnish (NFE)
AF:
0.578
AC:
39308
AN:
67976
Other (OTH)
AF:
0.574
AC:
1209
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1970
3940
5909
7879
9849
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.568
Hom.:
30129
Bravo
AF:
0.505
Asia WGS
AF:
0.218
AC:
759
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Quebec platelet disorder Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
6.0
DANN
Benign
0.59
PhyloP100
-0.011
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4065; hg19: chr10-75676464; API